ALK INHIBITORS

被引：0
|
作者：
Blackhall, F. [1 ]
机构：
[1] Christie NHS Fdn Trust, Manchester, Lancs, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S20 / S21
页数：2
相关论文
共 50 条
  • [21] Targeted Therapy for Neuroblastoma: ALK Inhibitors
    Schulte, J. H.
    Schulte, S.
    Heukamp, L. C.
    Astrahantseff, K.
    Stephan, H.
    Fischer, M.
    Schramm, A.
    Eggert, A.
    KLINISCHE PADIATRIE, 2013, 225 (06): : 303 - 308
  • [22] Second-Generation ALK Inhibitors
    Mano, Hiroyuki
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (07)
  • [23] Are All ALK Inhibitors Really Necessary?
    Hirano, Katsuya
    Kataoka, Yuki
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (12) : E152 - E153
  • [24] Toxicity profiles of ALK inhibitors differ
    Reactions Weekly, 2022, 1904 (1) : 12 - 12
  • [25] Analysis of clinical characteristics and outcomes of ALK positive (ALK plus ) patients treated with ALK inhibitors (ALKi).
    Perez, Susana Cedres
    Aranda, Nuria Pardo
    Navarro, Alejandro
    Marti, Alex Martinez
    de Castro, Ana Maria Martinez
    Cabrera, Guadalupe
    Vilaro, Marta
    Carbonell, LLuisa
    de la Fuente, Iris
    Piera, Adelaida
    Martinez, Lidia
    Hernandez-Losa, Javier
    Sansano, Irene
    Felip, Enriqueta
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells
    Bergaggio, Elisa
    Tai, Wei-Tien
    Aroldi, Andrea
    Mecca, Carmen
    Landoni, Elisa
    Nuesch, Manuel
    Mota, Ines
    Metovic, Jasna
    Molinaro, Luca
    Ma, Leyuan
    Alvarado, Diego
    Ambrogio, Chiara
    Voena, Claudia
    Blasco, Rafael B.
    Li, Tongqing
    Klein, Daryl
    Irvine, Darrell J.
    Papotti, Mauro
    Savoldo, Barbara
    Dotti, Gianpietro
    Chiarle, Roberto
    CANCER CELL, 2023, 41 (12) : 2100 - 2116.e10
  • [27] ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR- T cells
    Bergaggio, Elisa
    Tai, Wei-Tien
    Aroldi, Andrea
    Mecca, Carmen
    Landoni, Elisa
    Nuesch, Manuel
    Mota, Ines
    Metovic, Jasna
    Molinaro, Luca
    Ma, Leyuan
    Alvarado, Diego
    Ambrogio, Chiara
    Voena, Claudia
    Blasco, Rafael B.
    Li, Tongqing
    Klein, Daryl
    Irvine, Darrell J.
    Papotti, Mauro
    Savolodo, Barbara
    Dotti, Gianpietro
    Chiarle, Roberto
    CANCER RESEARCH, 2024, 84 (06)
  • [28] Impact of ALK inhibitors to potentiate ALK.CAR-T therapy in neuroblastoma
    Bergaggio, Elisa
    Chiarle, Roberto
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (06):
  • [29] A story of ALK variants and the efficacy of ALK inhibitors: moving toward precision oncology
    Tu, Hai-Yan
    Zhang, Yi-Chen
    Wu, Yi-Long
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S292 - S295
  • [30] Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid Tumors
    Takeyasu, Yuki
    Okuma, Hitomi S.
    Kojima, Yuki
    Nishikawa, Tadaaki
    Tanioka, Maki
    Sudo, Kazuki
    Shimoi, Tatsunori
    Noguchi, Emi
    Arakawa, Ayumu
    Mori, Taisuke
    Sunami, Kuniko
    Kubo, Takashi
    Kohno, Takashi
    Akihiko, Yoshida
    Yamamoto, Noboru
    Yonemori, Kan
    JCO PRECISION ONCOLOGY, 2021, 5 : 756 - 766
12345